FT819 in Subjects With B-cell Malignancies
Running, not enrolling · Phase 1
Conditions studied: Lymphoma, B-Cell, Chronic Lymphocytic Leukemia, Precursor B-Cell Acute Lymphoblastic Leukemia
In brief
This is a Phase I dose-finding study of FT819 as monotherapy and in combination with IL-2 in subjects with relapsed/refractory B-cell Lymphoma, Chronic Lymphocytic Leukemia and Precursor B-cell Acute Lymphoblastic Leukemia. The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts.
Key facts
- Study ID
- NCT04629729
- Run by
- Fate Therapeutics
- People needed
- 54
- Starts
- 2021-07-12
- Expected to finish
- 2039-09-30
- Last updated by the study team
- 2026-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Mayo Arizona — Phoenix, Arizona, United States
- UC Davis — Davis, California, United States
- Scripps Green Hospital — La Jolla, California, United States
- UCLA Ronald Reagan Medical Center — Los Angeles, California, United States
- Stanford Cancer Institute — Palo Alto, California, United States
- University of Florida — Gainesville, Florida, United States
- Mayo Florida — Jacksonville, Florida, United States
- University of Iowa — Iowa City, Iowa, United States
- The University of Kansas Cancer Center — Westwood, Kansas, United States
- Norton Cancer Institute, St. Matthews Campus — Louisville, Kentucky, United States
- Mayo Minnesota — Rochester, Minnesota, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Hackensack University Medical Center — Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Oregon Health & Sciences University — Portland, Oregon, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- University of Wisconsin-Madison — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.